Skip navigation

Alexion shares rise after report of approach by Roche

(Reuters) - Shares of Alexion Pharmaceuticals Inc <ALXN.O> rose more than 7 percent on Tuesday following a report that Swiss drugmaker Roche Holding AG <ROG.VX> made an informal approach to the biotech company last week about a takeover. Full story

Crop biotech company to expand by 150 jobs by 2018

A global agriculture biotechnology company is expanding its North Carolina operations with plans to add 150 new jobs within about five years. Full story

Biotech earnings & Apple breaking $450

   CNBC's Seema Mody provides an update on a slew of biotech results, and a boost in shares of Apple. Vertex reports upbeat results and strong sales of their cystic fibrosis drug.

Early Glance: Biotechnology companies

Shares of some top biotechnology companies are down at 10 a.m.: Full story

Exclusive: Amgen lines up BofA, JPM, Barclays to finance Onyx deal -sources

NEW YORK (Reuters) - Amgen Inc, the world's largest biotechnology company, has lined up Bank of America Corp, JPMorgan Chase & Co and Barclays Plc to finance a potential deal for Onyx Pharmaceuticals Inc, according to three people familiar with the matter. Full story

Biotech's boom, can it continue?

   Biotech stocks are some of the best performing S&P stocks this month. Chris Raymond, Robert W. Baird senior biotech analyst, shares his top picks.

Sponsored Links

Articles

A Biotech Investing Strategy for Retirees

Software and Biotech Companies Lead the Pack in VC Funding

3 Things That Could Slow Down Solazyme

Midday Glance: Biotechnology companies

Final Glance: Biotechnology companies

Should You Add Momenta to Your Portfolio?

What Is Biotechnology Again?

The Only True Biotech Dividend Stock

3 Best-Run Biotech Companies

Amgen share buybacks, drugs may fuel more stock gains - Barron's

Video

  Critics slam legislators for protecting GMO biotech firms

Melissa Harris-Perry reads a statement from Monsanto and the panel talks about a provision in a recent resolution from Congress that essentially protects GMO biotech firms and the seeds they produce from lawsuits over health risks.

  R&D For Your Portfolio: 3 Stocks in 3 Sectors

Mark Lehmann, JMP Securities president, provides investment strategies that include a biotech company with a promising drug to fight a rare form of Leukemia.

  Biogen IDEC CEO on Multiple Sclerosis Pill

Biotech has returned 20 percent for investors this year. Biogen IDEC CEO George Scangos, discusses the recent FDA approval of his company's drug, which is its first pill for multiple sclerosis.

  Nasdaq Biotech Index Up 16%

CNBC's Seema Mody has the latest on biotech from the Nasdaq.

  Amgen: Top Performing on the Nasdaq 100

CNBC's Seema Mody reports on big movers in Biotech after Affymax and Takeda recalled an anemia drug named Omontys.

advertisement | ad info

Related Photos

A general view shows Swiss biotech group Actelion Headquarters in Allschwil
A general view shows Swiss biotech group Actelion Headquarters in Allschwil

A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel, April 23, 2011. REUTERS/Christian Hartmann

France's President Francois Hollande visits "Onco Design", a biotechnology company, in Dijon
France's President Francois Hollande visits "Onco Design", a biotechnology company, in Dijon

France's President Francois Hollande listens during a visit at "Onco Design", a biotechnology company, in Dijon March 11, 2013 as part of a two-day trip in the Burgundy region. REUTERS/Eric Feferberg/Pool (FRANCE - Tags: POLITICS SCIENCE TECHNOLOGY)